Enhancing prognostic guidance in renal light-chain amyloidosis: a new staging system incorporating pathological characters
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.A new renal staging system for immunoglobulin light-chain amyloidosis, using amyloid score and estimated glomerular filtration rate, improves prognostic assessment for patients with kidney involvement. This system aids in predicting disease progression and guiding treatment decisions.
Area Of Science
- Nephrology
- Hematology
- Oncology
Background
- Renal immunoglobulin light-chain amyloidosis (AL) outcomes have improved with new treatments.
- A subset of patients experience renal adverse events despite hematologic response.
- Amyloid deposition patterns in renal tissue may explain treatment discrepancies.
Purpose Of The Study
- To develop a novel renal staging system for immunoglobulin light-chain amyloidosis.
- To incorporate pathological characteristics and clinical indicators for enhanced prognostic assessment.
- To improve risk stratification for patients with renal AL amyloidosis.
Main Methods
- Included 74 patients diagnosed via renal biopsy (2017-2022).
- Evaluated renal pathology using amyloid score (AS).
- Identified risk factors for end-stage renal disease (ESRD) or progression using a competing risk model to develop a renal staging system, validated by C-index, cross-validation, and Decision Curve Analysis (DCA).
Main Results
- 16 patients (21.6%) progressed to ESRD or experienced renal progression within 24.7 months.
- Amyloid score (AS) and estimated glomerular filtration rate (eGFR) were independent risk factors.
- The novel staging system (AS + eGFR) showed a C-index of 0.81, outperforming previous systems and confirmed by DCA.
Conclusions
- Amyloid score (AS) is a significant prognostic factor in Chinese patients with renal AL amyloidosis.
- The new renal staging system, based on AS and eGFR, offers valuable prognostic guidance.
- This system can aid clinicians in managing patients with renal AL amyloidosis.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
